Cooperative Agreement R13CA213938

This federal Project Grant award of $589,591.00 from the National Cancer Institute (CFDA 93.353 - 21st Century Cures Act - Beau Biden Cancer Moonshot) aims to determine how social factors may explain poorer survival outcomes for Black and Hispanic patients with Hodgkin lymphoma. The key products and services to be delivered under this 5-year project include: Examining differences in the receipt and quality of Hodgkin lymphoma treatment for initial diagnosis and relapse for those who have...

Federal Project Grant Award Summary Connecticut Children's Medical Center received a $156,340 project grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 15, 2025, with completion targeted by May 31, 2030. This Mentored Patient-Oriented Research Career Development (K23) award supports Dr. Siddika Mulchan's five-year research program investigating provider-focused interventions to improve health outcomes...

Federal Grant Award Summary Dr. Julia Rosenberg at Yale University received a $502,992 Career Development (K23) award from the National Institute on Minority Health and Health Disparities under the Minority Health and Health Disparities Research program (CFDA 93.307) beginning August 2, 2025, and concluding November 30, 2028. The award supports Dr. Rosenberg's transition to independent investigator status through a structured career development plan and accompanying research study addressing...

Federal Cooperative Agreement Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded a $12.84 million Cooperative Agreement to Harvard T.H. Chan School of Public Health on September 12, 2025, under the Oral Diseases and Disorders Research program (CFDA 93.121) to conduct the Pediatric HIV/AIDS Cohort Study (PHACS): Research on Immune Aging, Sexual and Reproductive Health, and Perinatal Acquisition: Elucidating Relationships in HIV (RISE). The five-year program,...

Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded Johns Hopkins University $105,076 through the Cancer Research Manpower program (CFDA 93.398) on February 15, 2026, to conduct a multi-method research study investigating electronic communication (e-communication) quality between pediatric cancer caregivers and healthcare teams. The project, with a completion date of August 14, 2027, examines how caregivers of children ages 0–13 undergoing active cancer treatment...

Federal Project Grant Summary Children's Hospital Los Angeles received an $8.47 million Project Grant from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded September 10, 2025, with completion targeted for August 31, 2029. The grant funds a patient navigation intervention designed to improve transition success for multiply disadvantaged young adult survivors of childhood cancer (CCS). The research addresses a critical gap in...

Federal Grant Award Summary The National Institute on Minority Health and Health Disparities awarded a $4.64 million Project Grant to the University of California, San Francisco on July 12, 2025, under the Minority Health and Health Disparities Research program (CFDA 93.307) to identify effective school-based health center (SBHC) models and practices nationally. This four-year mixed-methods study, extending through November 2028, will collect comprehensive national data on SBHC staffing models...

Federal Cooperative Agreement Summary The National Cancer Institute (NCI) awarded a $2.56 million Cooperative Agreement to The University of Texas MD Anderson Cancer Center under the Cancer Centers Support Grants program (CFDA 93.397) on August 22, 2025, with a completion date of July 31, 2030. This award funds a Lymphoma Outcomes Specialized Program of Research Excellence (SPORE) focused on addressing health disparities in lymphoma outcomes among African American and Hispanic patients. The...

Pons Incorporated received a $337,355 Project Grant award from the National Institute for Minority Health and Health Disparities under the Minority Health and Health Disparities Research program (CFDA 93.307) on September 17, 2025, for development of an automated image enhancement system to improve point-of-care ultrasound (POCUS) imaging in out-of-hospital settings. The project, scheduled for completion by August 31, 2026, addresses documented disparities in liver disease diagnosis and...

Federal Project Grant Award Summary The National Cancer Institute awarded a $1,302,284 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to the Regents of the University of Minnesota, effective May 6, 2025 through April 30, 2030. This research initiative investigates socioeconomic and stress-related immunobiological factors affecting pediatric hematopoietic cell transplant (HCT) outcomes. The primary deliverables include research findings quantifying the...